I
I

IMI

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.35%. * ASTRAZENECA: AstraZeneca AZN.L topped analyst expectations for second-quarter profit and revenue, helped by higher demand for its cancer medicines. * IAG: IAG IAG.L returned to quarterly profitability for the first time since the outbreak of the COVID-19 pandemic, following a "significant" increase in capacity.
A
C
E
G
G
I
I
J
R
S
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.2%. * STANCHART: Standard Chartered STAN.L on Friday reported that first-half pre-tax profit rose 19%, above market expectations, as the emerging markets-focused lender benefited from rising interest rates. * BUSINESS SENTIMENT: British business confidence fell this month to its lowest since March 2021 as companies worried about inflation, while pay pressures also increased, according to a
A
C
E
G
G
I
I
J
R
S
U

UK Stocks-Factors to watch on Feb 25

Feb 25 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 1.18%. * RIGHTMOVE: Rightmove's RMV.L 2021 profit surpassed pre-pandemic levels and the British real-estate portal said it expects transaction levels to stay strong, dispelling slowdown concerns driven by rising inflation and a higher cost of living.
B
C
E
I
J
P
R
I
U

UK Stocks-Factors to watch on Feb 25

Feb 25 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 1.21%. * CENTRICA: Britain's largest energy supplier Centrica CNA.L reported a doubling in adjusted profit for 2021 and said its British Gas brand had taken on about 700,000 customers after the collapse of rivals hit by soaring energy costs amid a cap on prices.
B
C
E
I
J
P
R
I
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.